Sex Differences in Arteriovenous Fistula Failure: Insights from Bioinformatics Analysis
Open Access
- 22 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (1) , 3
Abstract
(1) Background: Arteriovenous fistulas (AVFs) are the preferred access for hemodialysis. Unfortunately, about 60% of patients, especially female patients, fail to receive normal dialysis within one year after surgery because of AVF failure. However, the underlying mechanisms caused by sex differences in AVF failure remain unclear. (2) Methods: We performed analysis of DEGs and functional analysis with the dataset GSE119296 to reveal the biology underlying AVF failure. Immune responses were calculated using CIBERSORT. A protein–protein interaction network and hub gene were constructed using STRING and stepwise identification of potential drugs was performed online. (3) Results: Functional analysis showed that extracellular matrix reprogramming and PI3K-AKT pathway enrichment were significant in both male and female patients. COL1A1 was the hub gene in male patients, whereas CDK1 was the hub gene in female patients. Immune responses including γδ-T cells and mast cells are activated in female patients while no significant differences were noted in the male group. (4) Conclusions: In this study, we used a series of mature and recognized bioinformatic strategies to determine the following items: (1) Reveal the pathogenesis of AVF failure through HUB genes and signaling pathways between the different sexes. (2) Determine the relationship between sex differences in AVF failure and immune abnormalities. (3) Search for relevant sex-specific drugs targeting AVF failure.Keywords
Funding Information
- National Natural Science Foundation of China (81873529, 82000729)
This publication has 65 references indexed in Scilit:
- Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosisJournal Of Nephrology, 2014
- Gene Expression Changes in Venous Segment of Overflow Arteriovenous FistulaInternational Journal of Nephrology, 2013
- Systemic Barriers to Optimal Hemodialysis AccessSeminars in Nephrology, 2012
- Inflammation, Oxidation and Venous Neointimal Hyperplasia Precede Vascular Injury from AVF Creation in CKD PatientsThe Journal of Vascular Access, 2011
- Outcomes of Arteriovenous Fistula Creation after the Fistula First InitiativeClinical Journal of the American Society of Nephrology, 2011
- Inhibition of cyclooxygenase-2 modulates phenotypic switching of vascular smooth muscle cells during increased aortic blood flowHeart and Vessels, 2011
- Cellular phenotypes in human stenotic lesions from haemodialysis vascular accessNephrology Dialysis Transplantation, 2009
- Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice GuidelinesAmerican Journal of Kidney Diseases, 2004
- Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice GuidelinesAmerican Journal of Kidney Diseases, 2004
- Gender differences in outcomes of arteriovenous fistulas in hemodialysis patientsKidney International, 2003